Effectiveness of Gefitinib in Combination With Methotrexate in the Treatment of Ectopic Pregnancy

International Journal of Women's Health - New Zealand
doi 10.2147/ijwh.s55556
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Outpatient Methotrexate Treatment Strategies for Unruptured Tubal Ectopic Pregnancy

ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
2018English

Study of Single Dose Methotrexate for Medical Treatment of Ectopic Pregnancy

Journal of Medical Science And clinical Research
2019English

Early Predictive Factors of Single Dose Methotrexate Outcome in Patients With Ectopic Pregnancy

Archives of Gynecology and Obstetrics
MedicineGynecologyObstetrics
2019English

Pms41 - Cost-Effectiveness Analysis of Tofacitinib in Combination With Methotrexate in the Treatment of Moderate to Severe Rheumatoid Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Medical Treatment of Ectopic Pregnancy

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2006English

The Importance of Gestational Sac Size of Ectopic Pregnancy in Response to Single-Dose Methotrexate

ISRN Obstetrics and Gynecology
2013English

The Effectiveness of Different Treatments for Cesarean Ectopic Pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2018English

The Treatment of Cervical Pregnancy With Ultrasound-Guided Local Methotrexate Injection

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2017English

Expression of GNRHR at Tubal Ectopic Pregnancy Implantation Sites: Exploring the Potential for Treatment of Ectopic Pregnancy With GNRH Antagonists

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy